Valo Therapeutics Oy
2768695-4ActiveDeveloping novel peptide-coated oncolytic virus immunotherapies for cancer.
Biotechnology Companyvalotx.com
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2016
- Grunnlagt
Nøkkelbeslutningstakere
Marcella Origgi
Chief Executive Officer
@valotx.com+39340XXXXXXX
Matti Hautsalo
Member of the Board
@valotx.com
Lukasz Kuryk
Chief Development Officer
@valotx.com
Andrew Dean
Member of the Board
@valotx.com
+23 flere kontakter i Funnelfeedr
Beskrivelse
Valo Therapeutics (ValoTx) is a biotechnology company spun out from the University of Helsinki, specializing in cancer immunotherapy. The organization focuses on developing novel treatments by uniquely combining oncolytic virus therapy, peptide vaccination, and viral vector approaches. Their core pr...
Sox Therapeutics AB